MedTrace Logo

Predictors of Pregnancy Rate in Assisted Reproductive Technology According to Actual Guidelines

NCT04249297 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1150

Last updated 2021-12-28

No results posted yet for this study

Summary

Goals: To explore the association of probability of pregnancy with certain prognostic factors in patients undergoing assisted reproductive technology in Russian population according to international and national guidelines.

Conditions

Interventions

DRUG

Duphaston® (Dydrogesteron)

No intervention. Description of routine practice only. Prescribed Duphaston® according local marketing authorization and international and Russian In-Vitro Fertilization guidelines for luteal phase support as part of an Assisted Reproductive Technology (1 tablet 3 times a day starting at the day of oocyte retrieval).

Sponsors & Collaborators

Principal Investigators

  • Tatiana A Nazarenko, Prof · Kulakov National Medical Research Center of Obstetrics, Gynecology and Perinatology

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-03
Primary Completion
2022-03-31
Completion
2022-12-31

Countries

  • Kazakhstan
  • Russia

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04249297 on ClinicalTrials.gov